Preparation, Characterization and Stability Study of Oral Reconstitutable Suspension of Amoxicillin and Potassium Clavulanate

Pranit P Atpadikar (1) , Amol S Sherikar (2) , Mahanthesh M C (3) , Disouza J I (4)
(1) Department of Quality Assurance, Tatyasaheb Kore College of Pharmacy, Warananagar – 416 113, Maharashtra, India, India ,
(2) Department of Quality Assurance, Tatyasaheb Kore College of Pharmacy, Warananagar – 416 113, Maharashtra, India, India ,
(3) Department of Pharmacognosy, Tatyasaheb Kore College of Pharmacy, Warananagar – 416 113, Maharashtra, India, India ,
(4) Department of Quality Assurance, Tatyasaheb Kore College of Pharmacy, Warananagar – 416 113, Maharashtra, India, India

Abstract

To overcome the problem of bitter taste, degradation, and sedimentation, reconstitutable suspension of Amoxicillin and Potassium Clavulanate was prepared. The suspension was prepared by using two different formulations. The suspensions were characterized for micromeritic studies such as bulk density, tap density, Car’s index, angle of repose, pH, and viscosity. The HPLC assay was performed for the quantitative determination of Amoxicillin and Clavulanate potassium from suspension. The accelerated stability study was carried out to predict the stability profile of a drug product. Formulated reconstitutable suspension of Amoxicillin and Potassium Clavulanate has IPQC properties. From the results, it is concluded that reconstitutable suspension was successfully prepared and evaluated.

Full text article

Generated from XML file

References

S P Kaur, R Rao, and S Nanda. Amoxicillin: a broad spectrum antibiotic. Int J Pharm Pharm Sci, 3(3):30–37, 2011.

N Peace, O Olubukola, and A Moshood. Stability of reconstituted amoxicillin clavulanate potassium under simulated in-home storage conditions. J. Appl. Pharm. Sci, 2(1):28–31, 2012.

J G Avari and M Bhalekar. Cation exchange resins for taste masking and rapid dissolution of sparfloxacin. Indian Drugs-Bombay, 41(1):19–23, 2004.

C A Howard. Introduction to pharmaceutical dosage forms. pages 139–166, 1981. Lea and Febiger, Philadelphia, PA.

ICH Q1A (R2). (2003) Stability testing of new drug substances and products. 2003. International Conference on Harmonisation.

ICH Guidelines-Q1E. Evaluation of Stability Data. 2003.

J Swarbrick and J C Boylan. Encyclopedia of pharmaceutical technology. page 370, 2002. Marcel Dekker Inc., New York.

S B Bari, B M Mahajan, and S J Surana. Resistance to antibiotics: A challenge in chemotherapy. Indian Journal of Pharmaceutical Education and Research, 42(1):3–11, 2008.

L Prabakaran, M Bajpai, and T R Saini. Formulation development and optimization studies of satranidazole oral suspension. J Pharm Res, 4:19–23, 2005.

R J Parasimpathomimetics. Martindale-The Extra Pharmacopoeia. 1996. Royal Pharmaceutical Society. London, Р. 1413, 1428.

The United State Pharmacopoeia. 1995. Easton: Mack Publishing Company, p.1342.

The Indian Pharmacopoeia. 2007. Ministry of Health and Family Welfare, Government of India.

C R Raymond, J S Paul, and C O Sian. Handbook of pharmaceutical Excipients, The pharmaceutical Press and The American Pharmacist Association. 2006. p. 124-125, 743-747, 821-823.

The British Pharmacopoeia. 1988. The British Pharmacopoeia Commission, p. 105 & 192.

N A Pendharkar and D R Chaple. Simultaneous estimation of azithromycin and ambroxol hydrochloride in combined tablet dosage form by multicomponent mode of analysis. Asian Journal of Research in Chemistry, 3(2):3–5, 2010.

J Maurya. Role of process validation in pharmaceutical industry: an overview. Journal of Harmonized Research in Pharmacy, 2:151–172, 2013.

S Sharma and G Singh. Process Validation in Pharmaceutical Industry; An Overview. Journal of Drug Delivery and Therapeutics, 3(4):184–188, 2013.

M B Wazade, S R Walde, and A M Ittadwar. An Overview of Pharmaceutical Process Validation And Process Control Variables of Tablets Manufacturing Processes In Industry. International Journal of Pharmaceutical Sciences and Research, 3(9):3007–3022, 2012.

I R Berry and R A Nash. Pharmaceutical Process Validation. volume 101, pages 25–26, New York, 2013. Marcel Dekker, Inc, New York.

S Alam. An overview Pharmaceutical Process Validation. J. Adv. Pharm. Edu. and Res, 2:185– 200, 2013.

S S Patil, A S Sherikar, S Patil, and A Patil. Improvement of physicochemical characteristics and dissolution profile of poorly water soluble drug: ketoprofen by solid dispersion technique. Int. J. Res. Pharm. Sci, 1:1–4, 2010.

J N Addotey, L Awudzi, and R K Adosraku. Stability studies on reconstituted amoxicillinclavulanic acid oral powder by HPLC method development and quantification. International Journal of Pharmaceutical Science and Practice, 3(1):1–12, 2014.

Authors

Pranit P Atpadikar
Amol S Sherikar
assherikar.tkcp@gmail.com (Primary Contact)
Mahanthesh M C
Disouza J I
Pranit P Atpadikar, Amol S Sherikar, Mahanthesh M C, & Disouza J I. (2022). Preparation, Characterization and Stability Study of Oral Reconstitutable Suspension of Amoxicillin and Potassium Clavulanate. International Journal of Research in Pharmaceutical Sciences, 13(2), 231–239. https://doi.org/10.26452/ijrps.v13i2.452

Article Details

No Related Submission Found